AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
DISABILITY GRANTS FOR TUBERCULOSIS PATIENTS - A DISINCENTIVE TO COMPLETE TREATMENT
Authors: DICK J
Citation: J. Dick, DISABILITY GRANTS FOR TUBERCULOSIS PATIENTS - A DISINCENTIVE TO COMPLETE TREATMENT, South African medical journal, 85(6), 1995, pp. 549-550
HERODOTUS AND THE MULTIDISCIPLINARY CLINIC
Authors: SCHIPPER H DICK J
Citation: H. Schipper et J. Dick, HERODOTUS AND THE MULTIDISCIPLINARY CLINIC, Lancet, 346(8986), 1995, pp. 1312-1313
PERCUTANEOUS CHOLECYSTOLITHOTOMY - RISKS, BENEFITS, AND LONG-TERM OUTCOME
Authors: PEREIRA SP ELLUL JPM KEIGHTLEY A KENNEDY C DICK J DOWLING RH
Citation: Sp. Pereira et al., PERCUTANEOUS CHOLECYSTOLITHOTOMY - RISKS, BENEFITS, AND LONG-TERM OUTCOME, Scandinavian journal of gastroenterology, 30(5), 1995, pp. 484-488
USE OF 2-PERCENT PROPOFOL TO PRODUCE NIGHT SEDATION IN CRITICALLY ILLPATIENTS - EFFECT ON DIURNAL RHYTHM
Authors: MCLEOD G WALLIS C COX C PATTERSON A DICK J COLVIN J
Citation: G. Mcleod et al., USE OF 2-PERCENT PROPOFOL TO PRODUCE NIGHT SEDATION IN CRITICALLY ILLPATIENTS - EFFECT ON DIURNAL RHYTHM, British Journal of Anaesthesia, 74, 1995, pp. 113-113
USE OF 2-PERCENT PROPOFOL TO PRODUCE NIGHT SEDATION IN CRITICALLY ILLPATIENTS - EFFECT ON HORMONES
Authors: COX C MCLEOD G WALLIS C PATTERSON A DICK J COLVIN J
Citation: C. Cox et al., USE OF 2-PERCENT PROPOFOL TO PRODUCE NIGHT SEDATION IN CRITICALLY ILLPATIENTS - EFFECT ON HORMONES, British Journal of Anaesthesia, 74, 1995, pp. 114-114
USE OF 2-PERCENT PROPOFOL TO PRODUCE NIGHT SEDATION IN CRITICALLY ILLPATIENTS - EFFECT ON LIPIDS
Authors: MCLEOD G WALLIS G COX C DICK J PATTERSON A COLVIN J
Citation: G. Mcleod et al., USE OF 2-PERCENT PROPOFOL TO PRODUCE NIGHT SEDATION IN CRITICALLY ILLPATIENTS - EFFECT ON LIPIDS, British Journal of Anaesthesia, 74, 1995, pp. 114-114
TRANSPLANTATION OF CD34(-CORD BLOOD PROGENITOR CELLS INTO NONOBESE DIABETIC (NOD)() HUMAN (HU) UMBILICAL)SEVERS COMBINED IMMUNODEFICIENCY (SCID) MICE/
Authors: KELLER G HOGAN C MCBURNEY E HAMI L HELM K SHULTZ L DICK J MCNIECE I SHPALL E
Citation: G. Keller et al., TRANSPLANTATION OF CD34(-CORD BLOOD PROGENITOR CELLS INTO NONOBESE DIABETIC (NOD)() HUMAN (HU) UMBILICAL)SEVERS COMBINED IMMUNODEFICIENCY (SCID) MICE/, Blood, 86(10), 1995, pp. 2278-2278
EFFICACY OF OFLOXACIN VS CEFAZOLIN AND TOBRAMYCIN IN THE THERAPY FOR BACTERIAL KERATITIS - REPORT FROM THE BACTERIAL-KERATITIS-STUDY-RESEARCH-GROUP
Authors: OBRIEN TP MAGUIRE MG FINK NE ALFONSO E MCDONNELL P SHEPPARD JD BODNER BI RUSCH A OLSON RJ LUCIUS R JACKSON A LOIDENIX M MAMALIS N KEANEY R PFLUGFELDER S FORSTER RK HUANG A DELCALVO M SUTPHIN J DOHODA R BLANTON C TANNER G GOTTSCH D STARK WJ LIVINGSTON A BELIN MW GARZA D CUNNINGHAM RD CROFT K PENNELL J KIRKPATRICK P LUSTBADER J LEMP M PLAVNIEKS S FARRELL P SOONG HK MEYER RF SUGAR A WALDO M STAMLER JF VERDIER DD PERRY H DONNENFELD E KENYON K RAPOZA P MILLER D KENNEALLY M GRENE RB WELLEMEYER M LANKSTON P SERDAREVIC O KELLY L MATHERS WD STRIKE D FOURAKER B WILSON T ROWSEY JJ OLSAKOVSKY L JONES R KONEGER R ANRIYOSN R KUMAR S MCCULLEY J BURRIS TE BERGER M CHANDLER T HWANG D WHITCHER J LINDSTOM E REPASS R WALTERS T FUERST D SHULMAN D CONSTAD W DICK J OSTERHOUT G KERMAN J BAYTON P CHEETHAM JK ROSENTHAL A STOECKER J JENSEN H LAMBERT J CHEN KK LAPINSKI M CAMPOLONGO K FITCH L BRYANT B MEINDERS J
Citation: Tp. Obrien et al., EFFICACY OF OFLOXACIN VS CEFAZOLIN AND TOBRAMYCIN IN THE THERAPY FOR BACTERIAL KERATITIS - REPORT FROM THE BACTERIAL-KERATITIS-STUDY-RESEARCH-GROUP, Archives of ophthalmology, 113(10), 1995, pp. 1257-1265
VANCOMYCIN LEVELS IN THE VITREOUS CAVITY AFTER INTRAVENOUS ADMINISTRATION
Authors: MEREDITH TA AGUILAR HE SHAARAWY A KINCAID M DICK J NIESMAN MR
Citation: Ta. Meredith et al., VANCOMYCIN LEVELS IN THE VITREOUS CAVITY AFTER INTRAVENOUS ADMINISTRATION, American journal of ophthalmology, 119(6), 1995, pp. 774-778
CORD-BLOOD TRANSPLANTATION - AN UPDATE
Authors: BROXMEYER HE SRIVASTAVA A LU L RISDON G VORMOOR J DICK J RUBINSTEIN P KURTZBERG J WAGNER J
Citation: He. Broxmeyer et al., CORD-BLOOD TRANSPLANTATION - AN UPDATE, Experimental hematology, 22(8), 1994, pp. 677-677
PRESENCE OF CD34-1+ CELLS AND LTC-IC IN SCID MICE REPOPULATED WITH NORMAL HUMAN MARROW-CELLS(THY)
Authors: CASHMAN JD LAPIDOT T SCHULTZ L LANSDORP P EAVES CI DICK J
Citation: Jd. Cashman et al., PRESENCE OF CD34-1+ CELLS AND LTC-IC IN SCID MICE REPOPULATED WITH NORMAL HUMAN MARROW-CELLS(THY), Experimental hematology, 22(8), 1994, pp. 838-838
THE DESIGN OF A CASE REGISTER FOR TUBERCULOSIS - A PILOT-STUDY IN THESOUTH-WESTERN CAPE
Authors: DICK J YOUNGLESON SM
Citation: J. Dick et Sm. Youngleson, THE DESIGN OF A CASE REGISTER FOR TUBERCULOSIS - A PILOT-STUDY IN THESOUTH-WESTERN CAPE, South African medical journal, 84(9), 1994, pp. 621-623
A CLUSTER OF INVASIVE PNEUMOCOCCAL DISEASE IN YOUNG-CHILDREN IN CHILD-CARE
Authors: CHERIAN T STEINHOFF MC HARRISON LH ROHN D MCDOUGAL LK DICK J
Citation: T. Cherian et al., A CLUSTER OF INVASIVE PNEUMOCOCCAL DISEASE IN YOUNG-CHILDREN IN CHILD-CARE, JAMA, the journal of the American Medical Association, 271(9), 1994, pp. 695-697
PROLIFERATION AND EXPANSION OF CD34+ HUMAN PROGENITOR CELLS IN THE MARROW OF NOD SCID MICE
Authors: CASHMAN J LAPIDOT T TAKAHASHI J DOEDENS M LANSDORP P DICK J EAVES C
Citation: J. Cashman et al., PROLIFERATION AND EXPANSION OF CD34+ HUMAN PROGENITOR CELLS IN THE MARROW OF NOD SCID MICE, Blood, 84(10), 1994, pp. 10000368-10000368
AN ADENOVIRUS VECTOR FOR PURGING TUMOR-CELLS FROM BONE-MARROW
Authors: CLARKE MF NUNEZ G APEL IJ DICK J EIPERS PG
Citation: Mf. Clarke et al., AN ADENOVIRUS VECTOR FOR PURGING TUMOR-CELLS FROM BONE-MARROW, Blood, 84(10), 1994, pp. 10000500-10000500
COMPARISONS OF THERAPEUTIC EFFECTS OF LEVODOPA, LEVODOPA AND SELEGILINE, AND BROMOCRIPTINE IN PATIENTS WITH EARLY, MILD PARKINSONS-DISEASE - 3-YEAR INTERIM-REPORT
Authors: LEES AJ ABBOTT R BANERJI N BARRIE M BODDIE H BRADBURY P CLARKE C CLIFFORDJONES R CORSTON R CRITCHLEY E CRITCHLEY P CULL R DICK J DRAPER I ELLIS C FINDLEY L FOWLER T GALE A GARDNERTHORPE C GIBB W GIBSON JD GIBSON JM GODWINAUSTEN R GREENWOOD R HARDIE R HARLEY D HAWKES C HAWKINS S HILDICKSMITH M HUGHES R ILLIS L JESTICO J KAFETZ K KENNARD C KNIGHT R KOCEN R LEIGH N LOIZOU L LENTON R MACMAHON D MARSDEN CD MICHAEL W MITCHELL J MONRO P MORAN J MORGAN B MURDOCH P MUTCH W OVERSTALL P PARK D PARKES JD PENTLAND B PERKINS D PONSFORD R QUINN N RAWSON M REES J RIDDOCH D SCHON F SCHAPIRA A SHEPHERD D STERN G SUMMERS B TURNBULL C TURNER A VAKIL S WARD C WHITELEY A WILLIAMS A
Citation: Aj. Lees et al., COMPARISONS OF THERAPEUTIC EFFECTS OF LEVODOPA, LEVODOPA AND SELEGILINE, AND BROMOCRIPTINE IN PATIENTS WITH EARLY, MILD PARKINSONS-DISEASE - 3-YEAR INTERIM-REPORT, BMJ. British medical journal, 307(6902), 1993, pp. 469-472
USING MULTIATTRIBUTE UTILITY-THEORY AS A PRIORITY-SETTING TOOL IN HUMAN-SERVICES PLANNING
Authors: CAMASSO MJ DICK J
Citation: Mj. Camasso et J. Dick, USING MULTIATTRIBUTE UTILITY-THEORY AS A PRIORITY-SETTING TOOL IN HUMAN-SERVICES PLANNING, Evaluation and program planning, 16(4), 1993, pp. 295-304
PREVALENCE OF ROTAVIRUS ON HIGH-RISK FOMITES IN DAY-CARE FACILITIES
Authors: BUTZ AM FOSARELLI P DICK J CUSACK T YOLKEN R
Citation: Am. Butz et al., PREVALENCE OF ROTAVIRUS ON HIGH-RISK FOMITES IN DAY-CARE FACILITIES, Pediatrics, 92(2), 1993, pp. 202-205
IN-VITRO ACTIVATION OF HEMATOPOIETIC PROGENITORS WITH EXTENSIVE CAPACITIES FOR IN-VIVO PROLIFERATION
Authors: DUBE ID KAMELREID S KRUTH SA BIENZLE D ABRAMSOGG ACG DICK J CARTER R ACKLANDSNOW J
Citation: Id. Dube et al., IN-VITRO ACTIVATION OF HEMATOPOIETIC PROGENITORS WITH EXTENSIVE CAPACITIES FOR IN-VIVO PROLIFERATION, Blood, 82(10), 1993, pp. 10000016-10000016
ABERRANT GROWTH-PROPERTIES OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA (JCML) CD34-VITRO AND IN-VIVO USING SCID MOUSE ASSAYS( CELLS IN)
Authors: LAPIDOT T COHEN A GRUNBERGER T DICK J FREEDMAN MH
Citation: T. Lapidot et al., ABERRANT GROWTH-PROPERTIES OF JUVENILE CHRONIC MYELOGENOUS LEUKEMIA (JCML) CD34-VITRO AND IN-VIVO USING SCID MOUSE ASSAYS( CELLS IN), Blood, 82(10), 1993, pp. 10000197-10000197
Risultati: 1-25 | 26-45 |